Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

IPXLE

Impax labs (IPXLE)

Impax Laboratories (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:IPXLE
일자시간출처헤드라인심볼기업
2017/01/2006:27Dow Jones NewsRival to EpiPen Allergy Treatment to Return to Market--UpdateNASDAQ:IPXLEImpax Laboratories (MM)
2017/01/2005:17Dow Jones NewsRival to EpiPen Allergy Treatment to Return to MarketNASDAQ:IPXLEImpax Laboratories (MM)
2017/01/1307:03Dow Jones NewsCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- UpdateNASDAQ:IPXLEImpax Laboratories (MM)
2016/11/0405:08Dow Jones NewsDOJ Looking Into Possible Price Collusion in Generic Drug Sector -BloombergNASDAQ:IPXLEImpax Laboratories (MM)
2016/07/2808:41Dow Jones NewsCorrection to Teva, Allergan ArticleNASDAQ:IPXLEImpax Laboratories (MM)
2016/07/2805:00Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
2016/07/2804:51Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
2016/07/1308:20Dow Jones NewsTeva Raises GuidanceNASDAQ:IPXLEImpax Laboratories (MM)
2016/06/2216:07Dow Jones NewsBusiness Watch -- WSJNASDAQ:IPXLEImpax Laboratories (MM)
2016/06/2122:30Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
2016/06/2122:17Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
2016/04/0100:50Dow Jones NewsFTC Accuses Endo of Paying Off Generic DrugmakersNASDAQ:IPXLEImpax Laboratories (MM)
2015/09/2312:50Dow Jones NewsTuring to Cut Price of Drug Daraprim After OutcryNASDAQ:IPXLEImpax Laboratories (MM)
2005/08/0517:00Business WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
2005/08/0517:00Business WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
2005/08/0317:00Business WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
2005/08/0317:00Business WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
2005/06/2720:00Business WireIMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to beNASDAQ:IPXLEImpax Laboratories (MM)
2005/06/2021:01Business WireIMPAX to Increase Existing Credit FacilityNASDAQ:IPXLEImpax Laboratories (MM)
2005/05/0422:03Business WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
2005/05/0422:03Business WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
2005/05/0300:01Business WireCORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20NASDAQ:IPXLEImpax Laboratories (MM)
2005/05/0222:24Business WireIMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005NASDAQ:IPXLEImpax Laboratories (MM)
 검색 관련기사 보기:NASDAQ:IPXLE